Group | Health Systems and Policies

The Health Systems and Policies research group develops and applies methods to evaluate and validate health system interventions in real-world health systems. We place special attention on measuring systems effectiveness of essential health interventions and assessing policies, recognising the interrelatedness of all health system building blocks – governance, financing, human resources, informatics, technologies and infrastructure, and service delivery. We also focus on strengthening good governance of health systems and translating evidence to policy. The research group combines expertise in health system analysis, policy analysis and evaluation, and health economics.

We participate in the Consortium for Health Policy and Systems Analysis for Africa. This is an EU FP7 project which is dedicated to support teaching at Schools of Public Health in Africa and beyond.


Renggli S et al. Looking at the bigger picture: how the wider health financing context affects the implementation of the Tanzanian Community Health Funds. Health Policy Plan. 2019(in press). DOI: 10.1093/heapol/czy091

Agorinya I.A et al. Socio-demographic determinants of low birth weight: evidence from the Kassena-Nankana districts of the Upper East Region of Ghana. PLoS One. 2018;13(11):e0206207. DOI: 10.1371/journal.pone.0206207

Lenk E.J et al. Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: human African trypanosomiasis, leprosy, visceral leishmaniasis, chagas disease. PLoS Negl Trop Dis. 2018;12(3):e0006250. DOI: 10.1371/journal.pntd.0006250

Means A.R et al. Evaluating the sustainability, scalability, and replicability of an STH transmission interruption intervention: the DeWorm3 implementation science protocol. PLoS Negl Trop Dis. 2018;12(1):e0005988. DOI: 10.1371/journal.pntd.0005988

Merritt M.W, Sutherland C.S, Tediosi F. Ethical considerations for global health decision-making: justice-enhanced cost-effectiveness analysis of new technologies for Trypanosoma brucei gambiense. Public Health Ethics. 2018;11(3):275-292. DOI: 10.1093/phe/phy013